We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to Customer stories
  • PrimeSTAR GXL: a decisive component in characterizing viral RNA structures
  • Joining the fight against antibiotic resistance
  • Overcoming technical challenges in extracellular vesicle research
  • Sequencing grey matter
  • Unlocking cardiomyocyte heterogeneity: the role of transcription factors
  • Profiling transcription factors with CUT&RUN sequencing
Studying intragenic deletions in EBV genome with PrimeSTAR GXL PrimeSTAR GXL helps find EBV link to lymphoma
Home › About › BioView blog › Customer stories › PrimeSTAR GXL: a decisive component in characterizing viral RNA structures

BioView blog

  • Automation
    • Methods of detection for AMR surveillance
    • Optimizing agriculture screening with high-throughput genotyping
    • ICELL8 cx Single-Cell System and combinatorial indexing
    • Full-length scRNA-seq in white adipose tissue
    • Takara Bio Single-Cell Workshop, Spring 2021
    • Big problems from small bugs
    • Better biobanking with high-throughput qPCR
    • Top 5 considerations when automating single-cell sequencing
    • What's inside automated single-cell RNA-seq platforms?
  • Cancer research
    • Arc-well: sequence single-cell DNA from 30-year old FFPE samples
    • When Epstein-Barr virus becomes a chronic menace
    • Amplifying our understanding of breast cancer metastases
    • Cancer immunotherapy
    • Accurate detection of SNVs and CNVs from 5-cell inputs
  • Career spotlights
    • Career spotlight: territory manager
    • Career spotlight: senior inside sales representative
    • Career spotlight: manufacturing engineer
    • Career spotlight: senior lead development representative
    • Career spotlight: technical support scientist
  • Current events
    • National Hispanic Heritage Month
      • 2024
        • Dr. Nick Silva discusses his passion for training and supporting underrepresented students in our first National Hispanic Heritage Month spotlight interview
        • Dr. Loyda Morales Rodriguez discusses her Hispanic heritage and how it drives her passion for increasing diversity and inclusivity in clinical research
        • Dr. Darya Marchany-Rivera speaks about her passion for helping people—including Hispanic students—meet their goals and dreams
        • Dr. Dianne Laboy Cintrón talks about her experience as an underrepresented student—and studying an “underrepresented” part of the human genome
      • 2023
        • Dr. Jose Barbosa
        • Dr. Yadira Soto-Feliciano
        • Dr. Sarah Stewart
    • Identifying promising HIV vaccine strategies
    • Your spit can save your life
    • Controlling the spread of COVID-19 with direct saliva testing
    • The 2020 Nobel Prize in Chemistry for CRISPR
    • In memory of Hermann Bujard
    • Coronavirus publication: know your enemy
    • Dethroning king coronavirus with novel vaccines
    • Entering new worlds while staying in place
    • Working hard to meet production demands for SARS-CoV-2 testing
    • Shelter in place
    • Takara Bio plays a crucial role in fighting the novel coronavirus
    • Screening for novel coronavirus with one-step RT-qPCR: getting ahead of the outbreak
  • Customer stories
    • PrimeSTAR GXL: a decisive component in characterizing viral RNA structures
    • Joining the fight against antibiotic resistance
    • Overcoming technical challenges in extracellular vesicle research
    • Sequencing grey matter
    • Unlocking cardiomyocyte heterogeneity: the role of transcription factors
    • Profiling transcription factors with CUT&RUN sequencing
  • Gene editing
    • Measure twice, cut once
    • Successful knockout experiments part II
    • Successful knockout experiments part I
    • Efficient nonviral T-cell engineering using CRISPR
  • Research news
    • wellDA-seq: bridging the gap between genetic and epigenetic profiling
    • Engineered PsCas9 for therapeutic genome editing
    • Delivery of functionalized DNA origami into the cell nucleus
    • Demystifying and simplifying the lentiviral production and transduction workflow
    • On-demand pharmaceuticals in space
    • Amplify NGS libraries without bias
    • Takara Bio wins a Crabby!
    • A new hiPSC model for type 2 diabetes
    • TCR-seq methods: strengths, weaknesses, and rankings
    • A faster path to analysis for mAbs as therapeutic agents
    • Gene therapy takes a step forward
    • ICELL8 technology keeps cardiovascular research pumping
    • Women's Networking Event at AGBT 2020
    • Detecting infectious disease threats in a changing climate
    • Unraveling the world of microorganisms
    • Microbiomes in the brain and belly
    • Gaining insight into pulmonary arterial hypertension with purified exosomes
    • Total RNA-seq from human biofluids and EVs
    • Seq-ing the small
    • Taking the SMARTer approach to RNA-seq of FFPE tissues
  • Single-cell analysis
    • Optimized full-length single nuclei RNA sequencing (snRNA-seq) to propel crop innovation
    • ABRF publishes single-cell RNA-seq benchmarking study
    • Two RNA-seq approaches reveal resident memory T cells hold the power to reverse liver fibrosis
    • Combination of single-cell RNA-seq approaches yields insights into the brain
    • Combining droplet and full-length sequencing technologies for a complete picture
    • Smashing single-cell sequencing sensitivity
    • Change of heart: exploring transcriptional variation in cardiomyocytes
    • Accelerating chromatin mapping with single-cell ATAC-seq
    • Bringing epigenomic profiling to the single-cell biology stage
    • Using the power of RNA-seq to characterize brain cell types
  • Stem cell research
    • Tools for iPSC-derived disease model development
    • 20 years of human stem cell research
    • Maximize transduction efficiency in hematopoietic cells
  • Tips and troubleshooting
    • Scaling up: moving from research to large-scale RNA production for mRNA therapeutics
    • Why lyo-ready mixes are crucial for qPCR assay development
    • It's a snap! 9 considerations for easy multi-fragment cloning
    • Best practices for RNA-seq: Optimizing sample prep
    • Designing primers for site-directed mutagenesis
    • Qualities to look for in your ideal OEM partner
    • Understanding viral titration—behind the science
    • 4 factors to consider for immune repertoire profiling
    • 5 FACS tips for scRNA-seq
    • Choosing a his-tagged purification resin
    • 5 tips to make your single-cell RNA-seq experiments a success
    • Using UMIs in NGS experiments
    • Web and mobile apps
    • One-step vs. two-step RT-qPCR
    • Avoid DNA contamination in PCR
    • When your his-tagged constructs don't bind
  • Women in STEM
    • Women in Science Day 2022
    • Women in STEM interview: Christina Chang
    • Women in STEM interview: Kim Smith
  • That's Good Support!
  • About our blog
Need help?
Contact Sales
Studying intragenic deletions in EBV genome with PrimeSTAR GXL PrimeSTAR GXL helps find EBV link to lymphoma

Amplification of the complete SARS-CoV-2 genome: PrimeSTAR GXL emerges as a pivotal component

Date: October 31, 2023

Author: Takara Bio Blog Team

Categories: NGS

Bio View logo

As experts gear up for the Oxford Global NextGen Omics 2023 conference in London in November, we are always on the lookout for exciting ways researchers are applying great products to breakthrough technologies in next-gen sequencing. One of these technologies from Oxford Nanopore—long-read nanopore DNA and RNA sequencing—has gained recent traction due to its relatively low cost, scalability, and delivery of real-time sequencing data. It was used during the COVID-19 pandemic to rapidly sequence the genomes of SARS-CoV-2 and identify variants in order to combat spread of the virus.

Here we shine the spotlight on the work of Dr. Redmond Smyth, who has published a protocol in Nature Methods. The protocol uses this popular technology to characterize viral RNA structures, including SARS-CoV-2, with the help of Takara Bio’s PrimeSTAR GXL DNA Polymerase.

Dr. Smyth is an RNA biochemist and virologist working at the Helmholtz Institute of RNA-based Infection Research (HIRI) in Germany. His research investigates the mechanistic role of RNA structure in the replication and evolution of RNA viruses, such as HIV-1, influenza, and SARS-CoV-2. Originally from Ireland, Dr. Smyth pursued his undergraduate degree in Natural Sciences at the University of Cambridge, UK, where he specialized in Virology and Immunology. He completed his PhD at the Burnet Institute in Melbourne, Australia, where he investigated mechanisms underpinning genetic diversity in HIV-1. He then undertook a postdoctoral position at the IBMC in Strasbourg, France, where he received training in RNA biochemistry. During this time, he worked to gain a deeper understanding of how the HIV-1 genomic RNA is incorporated into viral particles. In 2015, he was recruited as a chargé de recherché (CR2) by the CNRS, France. Since 2018, he heads his own research group at the Helmholtz Institute.

Photo of Dr. Redmond Smyth

Dr. Redmond Smyth

Read on to learn more about Dr. Smyth’s work, and how other labs can use these same products and protocols as they explore this exciting sequencing technology.


Can you tell us about your team and the research focus of your lab? How does it align with the theme of the institute?

Our team comprises dedicated scientists with a profound interest in RNA biology and virology, with a special focus on RNA viruses. RNA viruses are a significant threat to human health and a key class of emerging infectious diseases, responsible for millions of deaths annually. A defining feature of these viruses is their RNA genome, which encodes all the proteins necessary for hijacking host cells.

Photo of Dr. Smyth lab team

Traditionally, infectious disease research has focused on developing drugs that bind to viral proteins to disrupt their function, but viral RNA genomes play a crucial role in regulating infection through their ability to fold into complex three-dimensional structures. These RNA structures interact with other molecules within the host cell to influence vital processes such as splicing, translation, immune evasion, and viral evolution. Due to their essential nature, viral RNA structure represents a novel and extremely attractive target for antiviral intervention.

Our research projects are focused on uncovering novel functional RNA structures present in RNA virus genomes. By studying these structures, we can gain valuable insights into how they impact viral replication and evolution. Some RNA structures function by binding to proteins or other nucleic acids, and our team is dedicated to investigating these complex interactions. Additionally, RNA structure may exist as alternative folds, each with its unique biological function. We address these issues by developing and applying innovative experimental techniques. Our ultimate goal is to identify novel, conserved and potentially druggable antiviral targets, which would open up completely new avenues for prevention and treatment of viral diseases.

Our lab is housed within the Helmholtz Institute for RNA-based Infection Research (HIRI), which is one of the few institutes in the world to focus on RNA and Infection. The HIRI mission is to better understand the role of RNA in infection processes and to harness this knowledge in the design of novel anti-infective strategies. Our mechanistic studies are a key part of the institute’s mission.

You recently published a novel method known as nanopore dimethylsulfate mutational profiling (Nano-DMS-MaP). How does the application of nanopore sequencing enhance the DMS-MaP workflow?

Our recent scientific breakthrough, Nano-DMS-MaP, marks a significant advancement in our methodological arsenal for probing RNA structures. The technique amalgamates two powerful tools—long-read nanopore sequencing and dimethylsulfate (DMS) mutational profiling—allowing us to achieve unprecedented resolution in structural analysis.

This advance is important because within cellular environments, RNA isoforms are expressed with sequence variations, often arising from phenomena like alternative splicing and diverse transcription start sites. Consequently, these seemingly minor differences in RNA sequences can significantly impact their folding patterns, leading to distinct functional outcomes.

Nanopore sequencing plays a transformative role in our approach. Unlike conventional short-read Illumina sequencing, which struggles with unambiguous assignment to specific transcript isoforms, nanopore sequencing offers long reads that can be uniquely mapped to individual RNA isoforms. This breakthrough capability enables us to deconvolute the structural intricacies of various RNA isoforms, providing a more comprehensive and precise understanding of their functions.

By harnessing the power of Nano-DMS-MaP, we recently made a notable discovery concerning the HIV-1 genome, where the folding patterns significantly diverge between spliced and unspliced RNAs, shedding light on how HIV-1 discriminates between these RNA types during viral assembly.

What were the primary challenges encountered during the development of this method? How did PrimeSTAR GXL assist in overcoming these hurdles?

The development of Nano-DMS-MaP presented its share of challenges. One of the major obstacles involved obtaining DNA molecules that sufficiently covered all potential splice junctions, thereby facilitating precise RNA isoform identification. To tackle this, we adopted the ultra-processive reverse transcriptase known as MarathonRT, which efficiently generated the requisite cDNA. Moreover, we confronted the challenge of amplifying diverse and complex cDNA into double-stranded DNA for sequencing. After extensive testing of various enzymes, PrimeSTAR GXL emerged as a pivotal component in overcoming this hurdle.

Your lab has a history of employing PrimeSTAR GXL in previous publications. What standout results have you achieved with this polymerase?

Indeed, our lab has utilized PrimeSTAR GXL in past investigations, and its consistent performance has been a mainstay of our work. In our ongoing endeavors to characterize the RNA structures of influenza viruses using Nano-DMS-MaP, PrimeSTAR GXL has repeatedly demonstrated its utility in rescuing experiments that that did not amplify with other enzymes.

Using PrimeSTAR GXL, we were also able to amplify the entire 30 kb SARS-CoV-2 sequence—something I still find remarkable.

This method has shown promising results in the study of HIV; how do you envision other scientists utilizing this protocol? What broad impact could this work have on the field of infectious diseases?

Nano-DMS-MaP's potential applications extend far beyond our laboratory. We anticipate that other researchers in the field of RNA biology will eagerly adopt this protocol for their investigations. With its versatility, straightforward workflow, and the ability to uncover high-resolution structural information at the isoform level, we hope Nano-DMS-MaP will become the gold standard for studying RNA structural variations.

In the realm of infectious disease research, this method opens a gateway to uncover novel RNA-regulatory mechanisms that were previously concealed. Pathogens often exploit RNA isoforms to code for different proteins. By applying Nano-DMS-MaP, researchers can now unveil specific RNA structures harbored within these transcripts and discover novel functional determinants that could serve as potential targets for innovative anti-viral strategies.

What are your lab's next major research goals?

Looking ahead, we aim to delve deeper into RNA folding by elucidating the mechanisms through which multiple RNA molecules interact to form inter-molecular complexes with distinct functions crucial to viral replication. Exploring the influence of cellular localization on viral RNA structure and function represents an additional exciting avenue for our research.


References

Bohn, P. et al. Nano-DMS-MaP allows isoform-specific RNA structure determination. Nature Methods, 20, 849–859 (2023).

Back to Blog Front

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us